Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.

Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives. [1]

Titolo	Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.
Publication Type	Journal Article
Authors	Franca, R [2], Favretto, D [3], Granzotto, M [4], Decorti, G [5], Rabusin, M [6], Stocco, G [7]
PubMed ID	28088906 [8]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/epratuzumab-and-blinatumomab-therapeutic-antibodies-treatment-pediatric-acute-lymphoblastic-leukemia#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/epratuzumab-and-blinatumomab-therapeutic-antibodies-treatment-pediatric-acute-lymphoblastic-leukemia
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=1007
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=2643
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=240
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=356
[6] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=223
[7] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=373
[8] http://www.ncbi.nlm.nih.gov/pubmed/28088906?dopt=Abstract